Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A Study Comparing Nivolumab, Nivolumab in Combination With Ipilimumab and Placebo in Participants With Localized Kidney Cancer Who Underwent Surgery to Remove Part of a Kidney

Multiple Cancer Types

The purpose of this study is to determine whether nivolmab alone or the combination of nivolumab and ipilimumab versus placebo, is safe and effective for delaying or preventing recurrence of cancer in patients who have experienced partial or entire removal of a kidney
Kidney (Renal Cell), Urologic
III
Beckermann, Kathryn
NCT03138512
VICCURO1953

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: